tirzepatide efficacy New Weight Loss Medical Advances. Exploring Products | by James J Busby Tirzepatide as Adjunct to Insulin

In a recent cohort study of more than 1.6 million people with T2D who had no prior diagnosis of 13 OACs, Wang et al., found that individuals with T2D treated with GLP-1 RAs versus insulin had a significant risk reduction in 10 of 13 OACs, including esophageal, colorectal, endometrial, gallbladder, kidney, liver, ovarian, and pancreatic cancer as well as meningioma and multiple myeloma

Some patients also add a body composition scan or a broader medical weight loss program

Where Body Composition Tracking Fits In Whether you microdose or follow full guidelines, tracking fat vs

Nat Rev Endocrinol 3 , 705712 (2007)

Iron acts as a tumor growth factor and is involved in cell cycle regulation, DNA metabolism, and cellular energy generation